Evaluation of Novel Risk Factors and Clinical Outcomes of Acute Myocardial Infarction
NCT ID: NCT02641184
Last Updated: 2016-02-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
3000 participants
OBSERVATIONAL
2015-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Incidence Rate of Heart Failure After Acute Myocardial Infarction With Optimal Treatment
NCT03297164
China PEACE-Retrospective AMI Study
NCT01624883
China Acute Myocardial Infarction Registry
NCT01874691
Clinical Features and Linked MEchanisms in Acute Risk-free AMI
NCT06716177
Survival and cArdiovascular eVents in Patients With Acute Myocardial Infarction
NCT06489080
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Myocardial necrosis, as evidenced by increased Creatine Kinase Isoenzyme (CK-MB) or troponin levels
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Yangzhou No.1 People's Hospital
OTHER
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
OTHER
Huaian first people's hospital
UNKNOWN
Zhejiang Provincial People's Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Xiao Ye, MD
Doctor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Baiming Qu, MD
Role: PRINCIPAL_INVESTIGATOR
Department of Cardiology, Zhejiang Provincial People's Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Zhejiang provincial people's hospital
Hangzhou, Zhejiang, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ZJPPH01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.